Xencor (XNCR) Other Working Capital Changes (2013 - 2026)
Xencor's (XNCR) quarterly Other Working Capital Changes came in at $2.4 million in Q1 2026, up 750.0% year-on-year from $281411.8 in Q1 2025, and up 116.27% on a QoQ basis from $1.1 million in Q4 2025.
Xencor (XNCR) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 9 years of Other Working Capital Changes data on file, last reported at $2.4 million in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 750.0% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $9.9 million, a 2800.27% increase from a year earlier, with the FY2025 full-year figure at $7.2 million, changed N/A from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $2.4 million, up from $1.1 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for XNCR reached as high as $6.9 million in Q2 2024 and fell as low as -$5.3 million in Q3 2025.
- Historically, Other Working Capital Changes has averaged -$774823.5 across 5 years, with a median of -$680000.0 in 2025.
- On a YoY basis, Other Working Capital Changes climbed as much as 1300.88% in 2023 and fell as far as 11666.67% in 2023.
- Year by year, Other Working Capital Changes stood at -$4.9 million in 2022, then tumbled by 89.52% to -$9.2 million in 2023, then surged by 36.1% to -$5.9 million in 2024, then jumped by 118.77% to $1.1 million in 2025, then soared by 116.27% to $2.4 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $2.4 million in Q1 2026, $1.1 million in Q4 2025, and -$216000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.17 Mn |
| Mar 31, 2026 | 2.17 Mn |
| Mar 31, 2026 | 2.17 Mn |
| Dec 31, 2025 | -680,000.00 |
| Dec 31, 2025 | -680,000.00 |
| Dec 31, 2025 | -680,000.00 |
| Sep 30, 2025 | -5.26 Mn |
| Sep 30, 2025 | -5.26 Mn |
| Sep 30, 2025 | -5.26 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | -5.06 Mn |
| Mar 31, 2025 | -5.06 Mn |
| Mar 31, 2025 | -5.06 Mn |
| Dec 31, 2024 | 169,000.00 |
| Dec 31, 2024 | 169,000.00 |
| Dec 31, 2024 | 169,000.00 |
| Sep 30, 2024 | -5.24 Mn |
| Sep 30, 2024 | -5.24 Mn |